Redmile Group as of Sept. 30, 2022
Portfolio Holdings for Redmile Group
Redmile Group holds 70 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 11.3 | $290M | 13M | 22.41 | |
Amicus Therapeutics (FOLD) | 8.8 | $227M | 22M | 10.44 | |
Krystal Biotech (KRYS) | 5.1 | $132M | 1.9M | 69.70 | |
Argenx Se Sponsored Adr (ARGX) | 3.8 | $99M | 280k | 353.05 | |
Pliant Therapeutics (PLRX) | 3.7 | $94M | 4.5M | 20.89 | |
Xenon Pharmaceuticals (XENE) | 3.3 | $86M | 2.4M | 36.10 | |
Beam Therapeutics (BEAM) | 3.3 | $85M | 1.8M | 47.64 | |
Livanova SHS (LIVN) | 3.0 | $78M | 1.5M | 50.77 | |
Igm Biosciences (IGMS) | 2.9 | $76M | 3.3M | 22.74 | |
1life Healthcare | 2.7 | $70M | 4.1M | 17.15 | |
Replimune Group (REPL) | 2.4 | $63M | 3.6M | 17.27 | |
Kymera Therapeutics (KYMR) | 2.4 | $63M | 2.9M | 21.77 | |
Iveric Bio | 2.4 | $61M | 3.4M | 17.94 | |
Celldex Therapeutics Com New (CLDX) | 2.2 | $56M | 2.0M | 28.11 | |
Deciphera Pharmaceuticals (DCPH) | 2.1 | $55M | 3.0M | 18.50 | |
Akero Therapeutics (AKRO) | 2.1 | $54M | 1.6M | 34.05 | |
Verve Therapeutics (VERV) | 2.0 | $52M | 1.5M | 34.35 | |
Regenxbio Inc equity us cm (RGNX) | 2.0 | $51M | 1.9M | 26.43 | |
Ventyx Biosciences (VTYX) | 1.8 | $48M | 1.4M | 34.91 | |
ImmunoGen | 1.6 | $41M | 8.5M | 4.78 | |
Nurix Therapeutics (NRIX) | 1.5 | $39M | 3.0M | 13.03 | |
Adc Therapeutics Sa SHS (ADCT) | 1.4 | $36M | 7.5M | 4.82 | |
Zymeworks | 1.4 | $36M | 5.8M | 6.15 | |
Penumbra (PEN) | 1.3 | $34M | 179k | 189.60 | |
Repare Therapeutics Ord (RPTX) | 1.3 | $33M | 2.7M | 12.13 | |
Anthem (ELV) | 1.2 | $32M | 71k | 454.24 | |
Science 37 Holdings | 1.2 | $32M | 20M | 1.61 | |
Prothena Corp SHS (PRTA) | 1.2 | $32M | 526k | 60.63 | |
Stryker Corporation (SYK) | 1.2 | $32M | 157k | 202.54 | |
Entrada Therapeutics (TRDA) | 1.2 | $31M | 2.0M | 15.76 | |
Medavail Holdings Ord | 1.0 | $27M | 35M | 0.78 | |
Oak Street Health | 1.0 | $26M | 1.1M | 24.52 | |
Absci Corp (ABSI) | 1.0 | $25M | 8.0M | 3.13 | |
The Beauty Health Company Com Cl A (SKIN) | 1.0 | $25M | 2.1M | 11.79 | |
Atara Biotherapeutics (ATRA) | 0.9 | $24M | 6.2M | 3.78 | |
Centene Corporation (CNC) | 0.9 | $22M | 283k | 77.81 | |
Scholar Rock Hldg Corp (SRRK) | 0.8 | $22M | 3.1M | 6.93 | |
Annexon (ANNX) | 0.8 | $22M | 3.5M | 6.18 | |
Augmedix (AUGX) | 0.8 | $21M | 14M | 1.45 | |
Rapt Therapeutics (RAPT) | 0.7 | $19M | 785k | 24.06 | |
Ionis Pharmaceuticals (IONS) | 0.7 | $18M | 408k | 44.23 | |
Gritstone Oncology Ord (GRTS) | 0.7 | $18M | 7.0M | 2.57 | |
Stevanato Group S P A Ord Shs (STVN) | 0.6 | $16M | 947k | 16.94 | |
Allakos (ALLK) | 0.6 | $16M | 2.5M | 6.12 | |
Shattuck Labs (STTK) | 0.6 | $15M | 5.6M | 2.70 | |
Allovir (ALVR) | 0.6 | $15M | 1.9M | 7.89 | |
Lava Therapeutics Nv SHS (LVTX) | 0.5 | $13M | 2.8M | 4.57 | |
Revolution Medicines (RVMD) | 0.5 | $12M | 625k | 19.72 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.4 | $11M | 82k | 133.29 | |
Stoke Therapeutics (STOK) | 0.4 | $11M | 836k | 12.84 | |
Bioventus Com Cl A (BVS) | 0.4 | $9.1M | 1.3M | 7.00 | |
Cutera (CUTR) | 0.3 | $8.9M | 195k | 45.60 | |
Humana (HUM) | 0.3 | $8.2M | 17k | 485.17 | |
Oncology Institu (TOI) | 0.3 | $7.3M | 1.6M | 4.63 | |
Alx Oncology Hldgs (ALXO) | 0.3 | $7.2M | 752k | 9.57 | |
Nuvation Bio Com Cl A (NUVB) | 0.3 | $6.8M | 3.0M | 2.24 | |
Hookipa Pharma Inc equity (HOOK) | 0.2 | $6.1M | 4.6M | 1.34 | |
Adagio Therapeutics (IVVD) | 0.2 | $6.0M | 1.9M | 3.13 | |
Invitae (NVTAQ) | 0.2 | $5.6M | 2.3M | 2.46 | |
Somalogic Class A Com | 0.2 | $5.4M | 1.9M | 2.90 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $3.6M | 1.6M | 2.26 | |
Stereotaxis Com New (STXS) | 0.1 | $2.7M | 1.5M | 1.80 | |
Neoleukin Therapeutics | 0.1 | $2.2M | 3.4M | 0.64 | |
Tcr2 Therapeutics Inc cs | 0.1 | $2.0M | 1.1M | 1.80 | |
Alpha Teknova (TKNO) | 0.1 | $1.9M | 558k | 3.34 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $1.6M | 1.0M | 1.56 | |
Atreca Cl A Com (BCEL) | 0.0 | $1.3M | 800k | 1.57 | |
Sonendo (SONX) | 0.0 | $533k | 498k | 1.07 | |
Cabaletta Bio (CABA) | 0.0 | $453k | 696k | 0.65 | |
Cytosorbents Corp Com New (CTSO) | 0.0 | $362k | 266k | 1.36 |